These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 9893262

  • 1. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
    Engel ME, Datta PK, Moses HL.
    J Cell Biochem Suppl; 1998; 30-31():111-22. PubMed ID: 9893262
    [Abstract] [Full Text] [Related]

  • 2. Signal transduction by transforming growth factor-β: A cooperative paradigm with extensive negative regulation.
    Engel ME, Datta PK, Moses HL.
    J Cell Biochem; 1998; 72 Suppl 30-31(S30-31):111-122. PubMed ID: 29345828
    [Abstract] [Full Text] [Related]

  • 3. Crossing Smads.
    Wrana JL.
    Sci STKE; 2000 Mar 14; 2000(23):re1. PubMed ID: 11752591
    [Abstract] [Full Text] [Related]

  • 4. [Signaling pathways of transforming growth factor beta family members].
    Zimowska M.
    Postepy Biochem; 2006 Mar 14; 52(4):360-6. PubMed ID: 17536504
    [Abstract] [Full Text] [Related]

  • 5. Regulation of transforming growth factor-beta signaling.
    Zhu HJ, Burgess AW.
    Mol Cell Biol Res Commun; 2001 Nov 14; 4(6):321-30. PubMed ID: 11703090
    [Abstract] [Full Text] [Related]

  • 6. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sugano Y, Yamashiki N, Nakagawa T, Seki T, Nishizawa M, Fujisawa J, Inoue K.
    Hepatology; 2000 Aug 14; 32(2):218-27. PubMed ID: 10915727
    [Abstract] [Full Text] [Related]

  • 7. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.
    Cancer Res; 2000 Aug 15; 60(16):4507-12. PubMed ID: 10969799
    [Abstract] [Full Text] [Related]

  • 8. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D, Mauviel A.
    Oncogene; 2005 Aug 29; 24(37):5742-50. PubMed ID: 16123807
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
    Tanaka H, Yamaba H, Kosugi N, Mizutani H, Nakata S.
    Arch Dermatol Res; 2008 Apr 29; 300 Suppl 1():S57-64. PubMed ID: 18060420
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 13. TGF-beta family signal transduction in Drosophila development: from Mad to Smads.
    Raftery LA, Sutherland DJ.
    Dev Biol; 1999 Jun 15; 210(2):251-68. PubMed ID: 10357889
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E, Mori Y, Sato F, Yin J, Olaru A, Sterian A, Xu Y, Wang S, Schulmann K, Berki A, Kan T, Abraham JM, Meltzer SJ.
    Cancer Res; 2004 Nov 01; 64(21):7690-6. PubMed ID: 15520171
    [Abstract] [Full Text] [Related]

  • 19. TGF-beta signaling, Smads, and tumor suppressors.
    Padgett RW, Das P, Krishna S.
    Bioessays; 1998 May 01; 20(5):382-90. PubMed ID: 9670811
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.